Minthon L - Search Results

1

Cerebrospinal fluid soluble TREM2 in aging and Alzheimer's disease.

Henjum K, Almdahl IS, Årskog V, Minthon L, Hansson O, Fladby T, Nilsson LN. Henjum K, et al. Among authors: minthon l. Alzheimers Res Ther. 2016 Apr 27;8(1):17. doi: 10.1186/s13195-016-0182-1. Alzheimers Res Ther. 2016. PMID: 27121148 Free PMC article.

2

Alterations of matrix metalloproteinases in the healthy elderly with increased risk of prodromal Alzheimer's disease.

Stomrud E, Björkqvist M, Janciauskiene S, Minthon L, Hansson O. Stomrud E, et al. Among authors: minthon l. Alzheimers Res Ther. 2010 Jun 24;2(3):20. doi: 10.1186/alzrt44. Alzheimers Res Ther. 2010. PMID: 20576109 Free PMC article.

3

Evaluation of CSF biomarkers as predictors of Alzheimer's disease: a clinical follow-up study of 4.7 years.

Hertze J, Minthon L, Zetterberg H, Vanmechelen E, Blennow K, Hansson O. Hertze J, et al. Among authors: minthon l. J Alzheimers Dis. 2010;21(4):1119-28. doi: 10.3233/jad-2010-100207. J Alzheimers Dis. 2010. PMID: 21504133 Free article.

4

Cerebrospinal fluid levels of β-amyloid 1-42, but not of tau, are fully changed already 5 to 10 years before the onset of Alzheimer dementia.

Buchhave P, Minthon L, Zetterberg H, Wallin AK, Blennow K, Hansson O. Buchhave P, et al. Among authors: minthon l. Arch Gen Psychiatry. 2012 Jan;69(1):98-106. doi: 10.1001/archgenpsychiatry.2011.155. Arch Gen Psychiatry. 2012. PMID: 22213792

5

Low levels of soluble NG2 in cerebrospinal fluid from patients with dementia with Lewy bodies.

Nielsen HM, Hall S, Surova Y, Nägga K, Nilsson C, Londos E, Minthon L, Hansson O, Wennström M. Nielsen HM, et al. Among authors: minthon l. J Alzheimers Dis. 2014;40(2):343-50. doi: 10.3233/JAD-132246. J Alzheimers Dis. 2014. PMID: 24448788

6

Changes in cerebrospinal fluid and blood plasma levels of IGF-II and its binding proteins in Alzheimer's disease: an observational study.

Hertze J, Nägga K, Minthon L, Hansson O. Hertze J, et al. Among authors: minthon l. BMC Neurol. 2014 Apr 1;14:64. doi: 10.1186/1471-2377-14-64. BMC Neurol. 2014. PMID: 24685003 Free PMC article.

7

Increased levels of hyaluronic acid in cerebrospinal fluid in patients with vascular dementia.

Nägga K, Hansson O, van Westen D, Minthon L, Wennström M. Nägga K, et al. Among authors: minthon l. J Alzheimers Dis. 2014;42(4):1435-41. doi: 10.3233/JAD-141200. J Alzheimers Dis. 2014. PMID: 25024336

8

Cerebrospinal fluid levels of IL-6 are decreased and correlate with cognitive status in DLB patients.

Wennström M, Hall S, Nägga K, Londos E, Minthon L, Hansson O. Wennström M, et al. Among authors: minthon l. Alzheimers Res Ther. 2015 Oct 5;7(1):63. doi: 10.1186/s13195-015-0145-y. Alzheimers Res Ther. 2015. PMID: 26434635 Free PMC article.

9

Preclinical effects of APOE ε4 on cerebrospinal fluid Aβ42 concentrations.

Lautner R, Insel PS, Skillbäck T, Olsson B, Landén M, Frisoni GB, Herukka SK, Hampel H, Wallin A, Minthon L, Hansson O, Blennow K, Mattsson N, Zetterberg H. Lautner R, et al. Among authors: minthon l. Alzheimers Res Ther. 2017 Oct 23;9(1):87. doi: 10.1186/s13195-017-0313-3. Alzheimers Res Ther. 2017. PMID: 29061195 Free PMC article.

10

Levels of islet amyloid polypeptide in cerebrospinal fluid and plasma from patients with Alzheimer's disease.

Schultz N, Janelidze S, Byman E, Minthon L, Nägga K, Hansson O, Wennström M. Schultz N, et al. Among authors: minthon l. PLoS One. 2019 Jun 17;14(6):e0218561. doi: 10.1371/journal.pone.0218561. eCollection 2019. PLoS One. 2019. PMID: 31206565 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

274 results

Search Page

Filters